Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host

被引:46
作者
Beer, B
Denner, J
Brown, CR
Norley, S
zur Megede, J
Coulibaly, C
Plesker, R
Holzammer, S
Baier, M
Hirsch, VM
Kurth, R
机构
[1] Paul Ehrlich Inst, D-63225 Langen, Germany
[2] NIAID, Mol Microbiol Lab, NIH, Twinbrook Facil 2, Rockville, MD USA
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1998年 / 18卷 / 03期
关键词
SIVagm; neonates; CD4(+) and CD8(+) lymphocytes; virus load; AIDS; pathogenesis; African green monkeys;
D O I
10.1097/00042560-199807010-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several studies have demonstrated that newborn animals are more susceptible to disease development following infection with retroviruses than adults. Adult African green monkeys (AGMs) infected with SIVagm do not develop AIDS-like disease and the objective of the study was to determine whether experimental infection of newborn AGMs with SIVagm would result in pathogenesis. Neonatal AGMs were found to have a higher percentage of circulating CD4(+) lymphocytes than adults (62% versus 14%) and therefore a higher potential pool of target cells for SIVagm infection. However, no differences in the in vitro replication kinetics of SIVagm in peripheral blood mononuclear cells of adult or neonatal AGMs could be observed. In vivo, the neonatal AGMs became viremic at the earliest two months after inoculation whereas the adult AGMs had evidence of virus replication already 2 to 6 weeks after infection. None of the animals developed AIDS-like symptoms upon infection. In the heterologous cynomolgus macaque host, a newborn infected with SIVagm developed early high virus loads and died two months after birth with AIDS-like histopathologic features. It would therefore appear that in contrast to the situation with many other retroviruses, newborn AGMs are no more permissive to SIVagm than are adults.
引用
收藏
页码:210 / 220
页数:11
相关论文
共 45 条
[1]   FLOW MICROFLUOROMETRIC ANALYSIS OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM NONHUMAN-PRIMATES - CORRELATION OF PHENOTYPE WITH IMMUNE FUNCTION [J].
AHMEDANSARI, A ;
BRODIE, AR ;
FULTZ, PN ;
ANDERSON, DC ;
SELL, KW ;
MCCLURE, HM .
AMERICAN JOURNAL OF PRIMATOLOGY, 1989, 17 (02) :107-131
[2]   ISOLATION AND CHARACTERIZATION OF SIMIAN IMMUNODEFICIENCY VIRUSES FROM 2 SUBSPECIES OF AFRICAN-GREEN MONKEYS [J].
ALLAN, JS ;
KANDA, P ;
KENNEDY, RC ;
COBB, EK ;
ANTHONY, M ;
EICHBERG, JW .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (03) :275-285
[3]   SPECIES-SPECIFIC DIVERSITY AMONG SIMIAN IMMUNODEFICIENCY VIRUSES FROM AFRICAN-GREEN MONKEYS [J].
ALLAN, JS ;
SHORT, M ;
TAYLOR, ME ;
SU, S ;
HIRSCH, VM ;
JOHNSON, PR ;
SHAW, GM ;
HAHN, BH .
JOURNAL OF VIROLOGY, 1991, 65 (06) :2816-2828
[4]   PATHOGENICITY OF LIVE, ATTENUATED SIV AFTER MUCOSAL INFECTION OF NEONATAL MACAQUES [J].
BABA, TW ;
JEONG, YS ;
PENNINCK, D ;
BRONSON, R ;
GREENE, MF ;
RUPRECHT, RM .
SCIENCE, 1995, 267 (5205) :1820-1825
[5]   MOLECULARLY CLONED SIMIAN IMMUNODEFICIENCY VIRUS SIVAGM3 IS HIGHLY DIVERGENT FROM OTHER SIVAGM ISOLATES AND IS BIOLOGICALLY-ACTIVE INVITRO AND INVIVO [J].
BAIER, M ;
WERNER, A ;
CICHUTEK, K ;
GARBER, C ;
MULLER, C ;
KRAUS, G ;
FERDINAND, FJ ;
HARTUNG, S ;
PAPAS, TS ;
KURTH, R .
JOURNAL OF VIROLOGY, 1989, 63 (12) :5119-5123
[6]   COMPLETE NUCLEOTIDE-SEQUENCE OF A SIMIAN IMMUNODEFICIENCY VIRUS FROM AFRICAN-GREEN MONKEYS - A NOVEL TYPE OF INTRAGROUP DIVERGENCE [J].
BAIER, M ;
GARBER, C ;
MULLER, C ;
CICHUTEK, K ;
KURTH, R .
VIROLOGY, 1990, 176 (01) :216-221
[7]   Lack of dichotomy between virus load of peripheral blood and lymph nodes during long-term simian immunodeficiency virus infection of African green monkeys [J].
Beer, B ;
Scherer, J ;
Megede, JZ ;
Norley, S ;
Baier, M ;
Kurth, R .
VIROLOGY, 1996, 219 (02) :367-375
[8]   Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivo [J].
Beer, B ;
Baier, M ;
zurMegede, J ;
Norley, S ;
Kurth, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :4062-4067
[9]  
BEER B, 1997, J ACQUIR IMMUNE D S1, V15, pS34
[10]  
BLUE ML, 1985, J IMMUNOL, V134, P2281